🍎 🍕 Less apples, more pizza 🤔 Have you seen Buffett’s portfolio recently?Explore for Free

Fauci backs COVID-19 vaccine mandate for U.S. school children

Published 08/29/2021, 12:53 PM
Updated 08/29/2021, 12:55 PM
© Reuters. FILE PHOTO: Top infectious disease expert Dr. Anthony Fauci testifies before the Senate Health, Education, Labor, and Pensions Committee on Capitol hill in Washington, D.C., U.S., July 20, 2021. J. Scott Applewhite/Pool via REUTERS
MRNA
-

By Linda So

WASHINGTON (Reuters) - Dr. Anthony Fauci, the top U.S. infectious disease expert, said on Sunday he supports COVID-19 vaccine mandates for children attending schools as the highly contagious Delta variant of the coronavirus continues to fuel a surge in cases in the nation.

"I believe that mandating vaccines for children to appear in school is a good idea," Fauci told CNN’s "State of the Union" program. "We've done this for decades and decades, requiring polio, measles, mumps, rubella, hepatitis" vaccinations.

Currently, children under 12 are not eligible to receive the COVID-19 vaccine. But Fauci, in a separate interview on ABC's "This Week" program, said there should be enough data by early October for the U.S. Food and Drug Administration to consider whether the shot is safe for children under that age.

"I think there's a reasonable chance" that the Pfizer-BioNTech or Moderna (NASDAQ:MRNA) vaccines could get FDA clearance for kids under 12 before the upcoming holiday season, Fauci, the director of the National Institute of Allergy and Infectious Diseases and chief medical adviser to the White House, said last Tuesday.

As schools re-open for the fall, the rise in coronavirus cases is already causing significant disruptions.

© Reuters. FILE PHOTO: Top infectious disease expert Dr. Anthony Fauci testifies before the Senate Health, Education, Labor, and Pensions Committee on Capitol hill in Washington, D.C., U.S., July 20, 2021. J. Scott Applewhite/Pool via REUTERS

Dozens of schools nationwide have had to delay the start of the school year or shut down since opening in August, according to data from tracking website Burbio https://cai.burbio.com/school-opening-tracker. Its data shows the impact on schools so far has been heaviest in the South, the epicenter of the current surge in cases and where vaccination rates among those already eligible are generally the lowest in the country.

The re-opening of schools is also contributing to a supply shortage of COVID-19 tests in the United States as schools revive surveillance programs that will require tens of millions of tests, according to industry executives and state health officials, Reuters reported https://www.reuters.com/world/us/us-covid-19-tests-again-short-supply-infections-soar-schools-reopen-2021-08-27 last week.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.